|
|
||||||||

Department of Virology, Armed Forces Research Institute of Medical Sciences, APO San Francisco 96346
The relative binding sites of dengue serotype-specific, dengue subcomplex-specific, dengue complex-specific, flavivirus subgroup-reactive, and flavivirus group-reactive monoclonal antibody preparations were identified by using competitive antibody binding assays. A dengue complex-specific epitope, capable of mediating infection enhancement, was identified on a 20,000 dalton protein found on intracellular virions. The other epitopes were assigned relative positions on the E glycoprotein by competitive antibody binding. These could be grouped into 3 linkage groups based on the ability of some monoclonal antibodies to block contiguous binding sites. Some antibodies were able to increase or "promote" the binding of antibodies from other linkage groups. These results suggest that a continuum of antigenic reactivities exist on the E glycoprotein of the dengue viruses, and that the conformation of this glycoprotein may be altered after antibody binding.
Accepted for publication July 2, 1984.
* Address reprint requests to: Dr. Walter E. Brandt, Department of Virus Diseases, Walter Reed Army Institute of Research, Washington, DC 20307.
This article has been cited by other articles:
![]() |
A. K. I. Falconar Use of synthetic peptides to represent surface-exposed epitopes defined by neutralizing dengue complex- and flavivirus group-reactive monoclonal antibodies on the native dengue type-2 virus envelope glycoprotein J. Gen. Virol., July 1, 2008; 89(7): 1616 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamanaka, S. Kosugi, and E. Konishi Infection-Enhancing and -Neutralizing Activities of Mouse Monoclonal Antibodies against Dengue Type 2 and 4 Viruses Are Controlled by Complement Levels J. Virol., January 15, 2008; 82(2): 927 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sukupolvi-Petty, S. K. Austin, W. E. Purtha, T. Oliphant, G. E. Nybakken, J. J. Schlesinger, J. T. Roehrig, G. D. Gromowski, A. D. Barrett, D. H. Fremont, et al. Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes J. Virol., December 1, 2007; 81(23): 12816 - 12826. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. van der Schaar, M. J. Rust, B.-L. Waarts, H. van der Ende-Metselaar, R. J. Kuhn, J. Wilschut, X. Zhuang, and J. M. Smit Characterization of the Early Events in Dengue Virus Cell Entry by Biochemical Assays and Single-Virus Tracking J. Virol., November 1, 2007; 81(21): 12019 - 12028. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Brown, C. A. King, C. Sherren, J. S. Marshall, and R. Anderson A dominant role for Fc{gamma}RII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release J. Leukoc. Biol., December 1, 2006; 80(6): 1242 - 1250. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |